Healthcare Education Services Alzheimer’s Disease: An Overview 2018
In-Person Event
Mar 22, 2018
London, England, GBSpeakers
OVERVIEW
Healthcare Education Services Alzheimer’s Disease: An Overview is organized by Healthcare Education Services and will be held on Mar 22, 2018 at London, England, United Kingdom. The target audience for this medical event is Neurologists.
Course Description:
A one-day training Alzheimer’s Disease course that is taught face-to-face. A programme designed to meet the educational needs of professionals from the pharmaceutical, medical technology, biotechnology and associated industries. Eminent specialist physicians and respected experts share their knowledge and experience with participants. Participants are provided with current information to better understand neurodegenerative disease and the neurobiology of cognitive impairment with a specific focus on Alzheimer’s Disease, its presentation and pharmacological treatment.
This training course is designed to meet the broad information and education requirements of a range of pharmaceutical, biotechnology and medical technology personnel. It is ideal for those from R&D, medical affairs, regulatory, strategic marketing and many others from both science and business functions. The day is interactive throughout. Lectures are interesting and inspirational, learning includes though provoking discussion and question and answer (Q&A). This course provides an excellent grounding for people new to this area of medicine. Those who have already been working in this field will enhance their knowledge and benefit from the clinical perspective provided by the programme.
Topics:
• Dementia – relevance of early diagnosis
• Cognitive impairment
• Alzheimer’s Disease – early onset and disease progression
• Clinical presentation and differential diagnosis – classification, differential diagnosis and biomarkers
• Pharmacological treatment including Acetylcholinesterase inhibitors, NMDA receptor antagonist and immunotherapy
• Ongoing research
Conference Objectives are :
• You will gain an overview of Alzheimer’s Disease
• Realise the disease from a clinical management and drug development perspective
• Gain information on neurodegenerative disease and
• Learn about the neurobiology of cognitive impairment
• Recognise clinical presentation
• Understand differential diagnosis including classification and biomarkers
• Review current pharmacological treatment including immunotherapy
• Discuss drugs in development
Additional details will be posted as soon as they are available.
Course Description:
A one-day training Alzheimer’s Disease course that is taught face-to-face. A programme designed to meet the educational needs of professionals from the pharmaceutical, medical technology, biotechnology and associated industries. Eminent specialist physicians and respected experts share their knowledge and experience with participants. Participants are provided with current information to better understand neurodegenerative disease and the neurobiology of cognitive impairment with a specific focus on Alzheimer’s Disease, its presentation and pharmacological treatment.
This training course is designed to meet the broad information and education requirements of a range of pharmaceutical, biotechnology and medical technology personnel. It is ideal for those from R&D, medical affairs, regulatory, strategic marketing and many others from both science and business functions. The day is interactive throughout. Lectures are interesting and inspirational, learning includes though provoking discussion and question and answer (Q&A). This course provides an excellent grounding for people new to this area of medicine. Those who have already been working in this field will enhance their knowledge and benefit from the clinical perspective provided by the programme.
Topics:
• Dementia – relevance of early diagnosis
• Cognitive impairment
• Alzheimer’s Disease – early onset and disease progression
• Clinical presentation and differential diagnosis – classification, differential diagnosis and biomarkers
• Pharmacological treatment including Acetylcholinesterase inhibitors, NMDA receptor antagonist and immunotherapy
• Ongoing research
Conference Objectives are :
• You will gain an overview of Alzheimer’s Disease
• Realise the disease from a clinical management and drug development perspective
• Gain information on neurodegenerative disease and
• Learn about the neurobiology of cognitive impairment
• Recognise clinical presentation
• Understand differential diagnosis including classification and biomarkers
• Review current pharmacological treatment including immunotherapy
• Discuss drugs in development
Additional details will be posted as soon as they are available.
KEY DATES
22 Mar, 2018
Event Start Date
22 Mar, 2018
Event End Date
SPECIALITIES
NeurologySUGGESTED HOTELS
CONFERENCE VENUE
TBDRELATED CONFERENCES & LIVE WEBINARS
Quick Links